ESC 365 - Comparative effectiveness and costs of enoxaparin versus unfractionated heparin in treating acute coronary syndrome

ESC Premium Access

Comparative effectiveness and costs of enoxaparin versus unfractionated heparin in treating acute coronary syndrome

Session: Poster Session 7 - Acute Coronary Syndromes - P2Y12 inhibitor

Topic: Pharmacotherapy

Speaker: Mrs A. Levorsen (NO)

Event: ESC Congress 2019

Congress Presentation

About the speaker

Mrs Andree Levorsen

(Norway)

0 follower

Access the full session

Poster Session 7 - Acute Coronary Syndromes - P2Y12 inhibitor

Speakers: Mrs A. Levorsen

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by